# Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease

> **NIH VA I01** · VETERANS HEALTH ADMINISTRATION · 2021 · —

## Abstract

There are more than 420,000 patients receiving maintenance hemodialysis therapy in the United States, which
is estimated to rise to over 500,000 patients by 2020. There are an estimated 45,500 veterans receiving
hemodialysis, of which over 3,000 enrolled veterans were receiving dialysis at VA facilities in FY 2013. Over
the last decade, there have been no therapies proven to significantly lower the mortality and morbidity risk for
these patients. One of the most important determinants of this poor clinical outcome is protein energy wasting,
a highly prevalent nutritional and metabolic abnormality characterized by increased protein breakdown in the
skeletal muscle compartment. Our group has shown that two well-recognized and interrelated metabolic
abnormalities, insulin resistance and persistent inflammation, are likely to play a critical role in the
pathogenesis of protein energy wasting and related nutritional and metabolic abnormalities. Our preliminary
data show that in maintenance hemodialysis (MHD) patients 1) There is an inadequate response to protein
anabolic actions of insulin; 2) Persistent systemic inflammation is strongly and independently associated with
skeletal muscle net protein balance; and 3) Pharmacological modulation of systemic inflammation and insulin
resistance partially, but not fully, reverse net protein catabolism. It was demonstrated that non-osmotic sodium
(Na) is stored in skin and muscle without commensurate water retention, which leads to local immune-cell
activation and accelerated pro-inflammatory status. Our preliminary data show that the skin and muscle Na+
contents, derived by 23Na magnetic resonance imaging (MRI) are substantially higher in MHD patients
compared to matched healthy controls. We also showed that increased skin and muscle Na concentrations
are significantly associated with increased inflammatory response and decreased peripheral insulin sensitivity,
in patients on MHD. These data suggest that tissue Na content, immune pathways and insulin resistance are
closely linked and could lead to increased risk for protein energy wasting in MHD patients. It was reported that
standard 4-hour conventional hemodialysis provides significant Na removal from muscle and skin suggesting
that tissue Na and water content could be modulated by modulating hemodialysis prescription. The overall goal
of this application is to elucidate the mechanisms by which tissue sodium accumulation, persistent immune
system activation and insulin resistance influence the development of protein energy wasting in MHD patients.
We hypothesize that the skin and muscle tissue sodium accumulation is a critical mechanism by which chronic
inflammatory response and insulin resistance, alone or in combination, lead to protein energy wasting in MHD
patients. Specific Aim 1: To test the hypothesis that excessive Na accumulation in the skeletal muscle and
skin leads to local and systemic inflammation that result in resistance to metabolic effects ...

## Key facts

- **NIH application ID:** 10041699
- **Project number:** 5I01CX001755-02
- **Recipient organization:** VETERANS HEALTH ADMINISTRATION
- **Principal Investigator:** TALAT Alp IKIZLER
- **Activity code:** I01 (R01, R21, SBIR, etc.)
- **Funding institute:** VA
- **Fiscal year:** 2021
- **Award amount:** —
- **Award type:** 5
- **Project period:** 2019-10-01 → 2023-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10041699

## Citation

> US National Institutes of Health, RePORTER application 10041699, Nutrition, Inflammation and Insulin Resistance in End-Stage Renal Disease (5I01CX001755-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10041699. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*